Structure Therapeutics Inc ADR (NASDAQ:GPCR) has a beta value of -1.46 and has seen 0.55 million shares traded in the recent trading session. The company, currently valued at $940.70M, closed the recent trade at $16.42 per share which meant it lost -$0.89 on the day or -5.14% during that session. The GPCR stock price is -282.1% off its 52-week high price of $62.74 and -4.99% below the 52-week low of $17.24. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.7 million shares traded. The 3-month trading volume is 800.99K shares.
The consensus among analysts is that Structure Therapeutics Inc ADR (GPCR) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.23.
Structure Therapeutics Inc ADR (NASDAQ:GPCR) trade information
Sporting -5.14% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the GPCR stock price touched $16.42 or saw a rise of 19.67%. Year-to-date, Structure Therapeutics Inc ADR shares have moved -39.45%, while the 5-day performance has seen it change -19.27%. Over the past 30 days, the shares of Structure Therapeutics Inc ADR (NASDAQ:GPCR) have changed -26.50%. Short interest in the company has seen 7.04 million shares shorted with days to cover at 8.18.
Wall Street analysts have a consensus price target for the stock at $93, which means that the shares’ value could jump 82.34% from the levels at last check today. The projected low price target is $65.0 while the price target rests at a high of $118.0. In that case, then, we find that the latest price level in today’s session is -618.64% off the targeted high while a plunge would see the stock gain -295.86% from the levels at last check today.
Structure Therapeutics Inc ADR (GPCR) estimates and forecasts
The company’s shares have lost -60.67% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -51.75% over the past 5 years. Earnings growth for 2025 is a modest 6.55% while over the next 5 years, the company’s earnings are expected to decrease by -25.24%.
GPCR Dividends
Structure Therapeutics Inc ADR is expected to release its next earnings report on 2025-Feb-26 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s Major holders
Insiders own 6.15% of the company shares, while shares held by institutions stand at 110.35% with a share float percentage of 117.59%. Investors are also buoyed by the number of investors in a company, with Structure Therapeutics Inc ADR having a total of 240.0 institutions that hold shares in the company. The top two institutional holders are WELLINGTON MANAGEMENT GROUP LLP with over 7.55 million shares worth more than $296.41 million. As of 2024-06-30, WELLINGTON MANAGEMENT GROUP LLP held 1.7124% of shares outstanding.
The other major institutional holder is FMR LLC, with the holding of over 5.74 million shares as of 2024-06-30. The firm’s total holdings are worth over $225.6 million and represent 1.3033% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are SMALLCAP WORLD FUND INC and VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund. As of Dec 31, 2024, the former fund manager holds about 7.74% shares in the company for having 4.44 shares of worth $73.51 million while later fund manager owns 4.25 shares of worth $70.41 million as of Jan 31, 2025, which makes it owner of about 7.41% of company’s outstanding stock.
